InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Discover the detailed record of transactions filed by GUSTAFSON MARK, Director. Director active across 1 companies, notably Alzamend Neuro, Inc.. In total, 8 reports have been logged. Total volume traded: €123k. The latest transaction was filed on 31 March 2022 — Cession. Regulator: SEC (Form 4). All data is free.
Declarations8 total
€21,85820,000 shares@ €1.09290.47% mcap17.8% of flow
Common Stock
SEC:0001214659-22-004803:0·
050,000 shares0
Common Stock
SEC:0001214659-22-003987:0·
€50,58420,000 shares@ €2.52921.09% mcap100.0% of flow
Common Stock
SEC:0001214659-21-013288·
€50,58420,000 shares@ €2.52921.09% mcap41.1% of flow
Common Stock
SEC:0001214659-21-013288:0·
047,222 shares0
Common Stock
SEC:0001214659-21-010559·
047,222 shares0
Common Stock
SEC:0001214659-21-010559:0·
02,778 shares0
Common Stock
SEC:0001214659-21-009539·
02,778 shares0
Common Stock
SEC:0001214659-21-009539:0·
8 of 8 declarations
About GUSTAFSON MARK
Mark Gustafson serves as a Board Member at Alzamend Neuro, Inc. In this role, he contributes to the governance of the company and strategic decision-making. His experience in the biotechnology sector allows him to provide valuable insights into operations and market challenges. He also ensures that the company adheres to ethical and regulatory standards.
